Delphx Capital signs LOI with Belgravia Hartford

Executive Summary

• Delphx Capital Markets Inc. entered into a non-binding Letter of Intent (LOI) with Belgravia Hartford Capital Inc. to execute the first commercial transaction for Delphx's Quantem Crypto Security (QCS) platform, involving a collateralized put option to protect corporate Bitcoin treasury holdings.
• The company announced a transition in its Chief Financial Officer role, with Bill Hahn departing and Simon Selkrig returning to the position effective January 1, 2026.
• The Board of Directors approved the grant of 2,875,000 stock options to eligible participants under the company's stock option plan.

Key Details

• Strategic Agreement (LOI):
  • Parties: Delphx Capital Markets Inc. and Belgravia Hartford Capital Inc.
  • Objective: Collaboration on the first anticipated commercial transaction of Delphx's Quantem Crypto Security (QCS).
  • Transaction Structure: Belgravia is expected to become the first corporate purchaser of a QCS collateralized put option, designed to protect and preserve corporate Bitcoin treasury holdings.
  • Advisory Support: Belgravia will provide advisory and structuring support, including assistance with program documentation, compliance processes, and onboarding coordination with the designated placement agent.
  • Conditions: The transaction is subject to negotiation and execution of definitive documentation, regulatory approvals, market conditions, and other customary closing conditions.
  • Binding Nature: The LOI is non-binding, except for customary confidentiality, regulatory compliance, and public disclosure provisions. Either party may terminate the LOI at any time.
  • Assurance: There is no assurance that the transaction will be completed.
• Management Changes:
  • Departing CFO: Bill Hahn is departing to pursue another opportunity.
  • Incoming CFO: Simon Selkrig is appointed as the new Chief Financial Officer, effective January 1, 2026. Selkrig previously served as CFO and brings familiarity with the company's financial reporting and capital markets requirements.
• Stock Option Grant:
  • Quantity: 2,875,000 stock options granted to eligible participants.
  • Exercise Price: $0.08 (eight cents) per common share.
  • Maturity: Two-year maturity.
  • Authority: Approved by the Board of Directors under the existing stock option plan.
• Company Overview (Boilerplate):
  • Delphx is a technology and financial services company focused on structured products.
  • Through its SPV, Quantem LLC, it enables broker-dealers to offer private placement securities with fixed-income and cryptocurrency-based solutions.
  • Proprietary products include Collateralized Put Options (CPOs) and Collateralized Reference Notes (CRNs), which are fully collateralized and held in custody by U.S. Bank.

Notable Quotes

• "Delphx further announces that it is pleased to welcome back Simon Selkrig, who has previously served as the company's chief financial officer, as its new chief financial officer, effective Jan. 1, 2026. The company believes Mr. Selkrig's prior experience with Delphx and familiarity with its financial reporting and capital markets requirements will support continuity as the company advances its strategic initiatives."